About the Authors
- Robert A. Smith
-
* E-mail: smithra@u.washington.edu
Affiliation Department of Pathology, University of Washington, Seattle, Washington, United States of America
- Dana N. Raugi
-
Affiliation Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America
- Charlotte Pan
-
Affiliation Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America
- Matthew Coyne
-
Affiliation College of Arts and Sciences, University of Washington, Seattle, Washington, United States of America
- Alexandra Hernandez
-
Affiliation College of Arts and Sciences, University of Washington, Seattle, Washington, United States of America
- Brad Church
-
Affiliation College of Arts and Sciences, University of Washington, Seattle, Washington, United States of America
- Kara Parker
-
Affiliation College of Arts and Sciences, University of Washington, Seattle, Washington, United States of America
- James I. Mullins
-
Affiliation Department of Microbiology, University of Washington, Seattle, Washington, United States of America
- Papa Salif Sow
-
Affiliation Clinique des Maladies Infectieuses Ibrahima DIOP Mar, Centre Hospitalier Universitaire de Fann, Université Cheikh Anta Diop de Dakar, Dakar, Senegal
- Geoffrey S. Gottlieb2 for the University of Washington–Dakar HIV-2 Study Group
-
¶Membership of the University of Washington–Dakar HIV-2 Study Group is provided in the Acknowledgments.
Competing Interests
Elvitegravir was provided by Gilead Sciences, Inc. for this study. This does not alter the authors’ adherence to all PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RS GG JM PSS. Performed the experiments: RS DNR CP MC AH BC KP. Analyzed the data: RS GG. Wrote the paper: RS GG.